Compare GNSS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNSS | NSPR |
|---|---|---|
| Founded | 1992 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.1M | 72.1M |
| IPO Year | 1996 | 2009 |
| Metric | GNSS | NSPR |
|---|---|---|
| Price | $1.89 | $1.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.75 | $4.00 |
| AVG Volume (30 Days) | ★ 96.8K | 47.9K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,306,790.00 | $2,310,000.00 |
| Revenue This Year | $80.08 | $57.98 |
| Revenue Next Year | N/A | $95.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.50 | N/A |
| 52 Week Low | $1.40 | $1.19 |
| 52 Week High | $2.70 | $2.93 |
| Indicator | GNSS | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 23.23 |
| Support Level | $1.87 | N/A |
| Resistance Level | $2.05 | $2.47 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 41.68 | 5.33 |
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.